Tag Archives: Pfizer

Pfizer rolls out Retacrit, a biosim to Amgen and J&J anemia blockbusters, at a big discount

After experiencing slow uptake for its first biosim launch, Pfizer isn’t giving up on the budding field. On Wednesday, the drugmaker introduced its third biosim, and second in two months, launching anemia treatment Retacrit at a significant discount to Amgen’s Epogen and Johnson & Johnson’s Procrit. Pfizer started shipping Retacrit to wholesalers on Monday at… Read More »

Mylan and Pfizer report new issues affecting some EpiPens that can delay treatment

More than a month after Mylan and Pfizer reported to Health Canada that there are new issues affecting some EpiPens, the companies and the FDA notified U.S. healthcare providers of the problem which can delay treatment when the pens are needed. Mylan, Pfizer and the FDA Friday reported that some pens and their authorized generic… Read More »